Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Global mismatch of policy and research on drivers of biodiversity loss.

Mazor T, Doropoulos C, Schwarzmueller F, Gladish DW, Kumaran N, Merkel K, Di Marco M, Gagic V.

Nat Ecol Evol. 2018 Jul;2(7):1071-1074. doi: 10.1038/s41559-018-0563-x. Epub 2018 May 21.

PMID:
29784980
2.

Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study.

Dvorak CC, Satwani P, Stieglitz E, Cairo MS, Dang H, Pei Q, Gao Y, Wall D, Mazor T, Olshen AB, Parker JS, Kahwash S, Hirsch B, Raimondi S, Patel N, Skeens M, Cooper T, Mehta PA, Grupp SA, Loh ML.

Pediatr Blood Cancer. 2018 Jul;65(7):e27034. doi: 10.1002/pbc.27034. Epub 2018 Mar 12.

PMID:
29528181
3.

Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia.

Stieglitz E, Mazor T, Olshen AB, Geng H, Gelston LC, Akutagawa J, Lipka DB, Plass C, Flotho C, Chehab FF, Braun BS, Costello JF, Loh ML.

Nat Commun. 2017 Dec 19;8(1):2127. doi: 10.1038/s41467-017-02178-9.

4.

Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas.

Hayes J, Yu Y, Jalbert LE, Mazor T, Jones LE, Wood MD, Walsh KM, Bengtsson H, Hong C, Oberndorfer S, Roetzer T, Smirnov IV, Clarke JL, Aghi MK, Chang SM, Nelson SJ, Woehrer A, Phillips JJ, Solomon DA, Costello JF.

Neuro Oncol. 2018 Apr 9;20(5):632-641. doi: 10.1093/neuonc/nox205.

PMID:
29077933
5.

Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1.

Mazor T, Chesnelong C, Pankov A, Jalbert LE, Hong C, Hayes J, Smirnov IV, Marshall R, Souza CF, Shen Y, Viswanath P, Noushmehr H, Ronen SM, Jones SJM, Marra MA, Cairncross JG, Perry A, Nelson SJ, Chang SM, Bollen AW, Molinaro AM, Bengtsson H, Olshen AB, Weiss S, Phillips JJ, Luchman HA, Costello JF.

Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):10743-10748. doi: 10.1073/pnas.1708914114. Epub 2017 Sep 15.

6.

Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas.

Wahl M, Chang SM, Phillips JJ, Molinaro AM, Costello JF, Mazor T, Alexandrescu S, Lupo JM, Nelson SJ, Berger M, Prados M, Taylor JW, Butowski N, Clarke JL, Haas-Kogan D.

Cancer. 2017 Dec 1;123(23):4631-4639. doi: 10.1002/cncr.30909. Epub 2017 Jul 31.

7.

Global analysis of depletion and recovery of seabed biota after bottom trawling disturbance.

Hiddink JG, Jennings S, Sciberras M, Szostek CL, Hughes KM, Ellis N, Rijnsdorp AD, McConnaughey RA, Mazor T, Hilborn R, Collie JS, Pitcher CR, Amoroso RO, Parma AM, Suuronen P, Kaiser MJ.

Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8301-8306. doi: 10.1073/pnas.1618858114. Epub 2017 Jul 17.

8.

Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas.

Kohanbash G, Carrera DA, Shrivastav S, Ahn BJ, Jahan N, Mazor T, Chheda ZS, Downey KM, Watchmaker PB, Beppler C, Warta R, Amankulor NA, Herold-Mende C, Costello JF, Okada H.

J Clin Invest. 2017 Apr 3;127(4):1425-1437. doi: 10.1172/JCI90644. Epub 2017 Mar 20.

9.

Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process.

Ohba S, Mukherjee J, Johannessen TC, Mancini A, Chow TT, Wood M, Jones L, Mazor T, Marshall RE, Viswanath P, Walsh KM, Perry A, Bell RJ, Phillips JJ, Costello JF, Ronen SM, Pieper RO.

Cancer Res. 2016 Nov 15;76(22):6680-6689. doi: 10.1158/0008-5472.CAN-16-0696. Epub 2016 Oct 6.

10.

Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors.

Sherborne AL, Lavergne V, Yu K, Lee L, Davidson PR, Mazor T, Smirnoff IV, Horvai AE, Loh M, DuBois SG, Goldsby RE, Neglia JP, Hammond S, Robison LL, Wustrack R, Costello JF, Nakamura AO, Shannon KM, Bhatia S, Nakamura JL.

Clin Cancer Res. 2017 Apr 1;23(7):1852-1861. doi: 10.1158/1078-0432.CCR-16-0610. Epub 2016 Sep 28.

11.

Intratumoral Heterogeneity of the Epigenome.

Mazor T, Pankov A, Song JS, Costello JF.

Cancer Cell. 2016 Apr 11;29(4):440-451. doi: 10.1016/j.ccell.2016.03.009. Review.

12.

Corrigendum: The genomic landscape of juvenile myelomonocytic leukemia.

Stieglitz E, Taylor-Weiner AN, Chang TY, Gelston LC, Wang YD, Mazor T, Esquivel E, Yu A, Seepo S, Olsen SR, Rosenberg M, Archambeault SL, Abusin G, Beckman K, Brown PA, Briones M, Carcamo B, Cooper T, Dahl GV, Emanuel PD, Fluchel MN, Goyal RK, Hayashi RJ, Hitzler J, Hugge C, Liu YL, Messinger YH, Mahoney DH Jr, Monteleone P, Nemecek ER, Roehrs PA, Schore RJ, Stine KC, Takemoto CM, Toretsky JA, Costello JF, Olshen AB, Stewart C, Li Y, Ma J, Gerbing RB, Alonzo TA, Getz G, Gruber TA, Golub TR, Stegmaier K, Loh ML.

Nat Genet. 2016 Jan;48(1):101. doi: 10.1038/ng0116-101a. No abstract available.

PMID:
26711114
13.

Sensitivity analysis of conservation targets in systematic conservation planning.

Levin N, Mazor T, Brokovich E, Jablon PE, Kark S.

Ecol Appl. 2015 Oct;25(7):1997-2010.

PMID:
26591464
14.

The genomic landscape of juvenile myelomonocytic leukemia.

Stieglitz E, Taylor-Weiner AN, Chang TY, Gelston LC, Wang YD, Mazor T, Esquivel E, Yu A, Seepo S, Olsen S, Rosenberg M, Archambeault SL, Abusin G, Beckman K, Brown PA, Briones M, Carcamo B, Cooper T, Dahl GV, Emanuel PD, Fluchel MN, Goyal RK, Hayashi RJ, Hitzler J, Hugge C, Liu YL, Messinger YH, Mahoney DH Jr, Monteleone P, Nemecek ER, Roehrs PA, Schore RJ, Stine KC, Takemoto CM, Toretsky JA, Costello JF, Olshen AB, Stewart C, Li Y, Ma J, Gerbing RB, Alonzo TA, Getz G, Gruber T, Golub T, Stegmaier K, Loh ML.

Nat Genet. 2015 Nov;47(11):1326-1333. doi: 10.1038/ng.3400. Epub 2015 Oct 12. Erratum in: Nat Genet. 2015 Nov;47(11):1333. Nat Genet. 2016 Jan;48(1):101.

15.

DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors.

Mazor T, Pankov A, Johnson BE, Hong C, Hamilton EG, Bell RJA, Smirnov IV, Reis GF, Phillips JJ, Barnes MJ, Idbaih A, Alentorn A, Kloezeman JJ, Lamfers MLM, Bollen AW, Taylor BS, Molinaro AM, Olshen AB, Chang SM, Song JS, Costello JF.

Cancer Cell. 2015 Sep 14;28(3):307-317. doi: 10.1016/j.ccell.2015.07.012.

16.

Emerging conservation challenges and prospects in an era of offshore hydrocarbon exploration and exploitation.

Kark S, Brokovich E, Mazor T, Levin N.

Conserv Biol. 2015 Dec;29(6):1573-85. doi: 10.1111/cobi.12562. Epub 2015 Jul 28. Review.

PMID:
26219342
17.

Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.

van Thuijl HF, Mazor T, Johnson BE, Fouse SD, Aihara K, Hong C, Malmström A, Hallbeck M, Heimans JJ, Kloezeman JJ, Stenmark-Askmalm M, Lamfers ML, Saito N, Aburatani H, Mukasa A, Berger MS, Söderkvist P, Taylor BS, Molinaro AM, Wesseling P, Reijneveld JC, Chang SM, Ylstra B, Costello JF.

Acta Neuropathol. 2015 Apr;129(4):597-607. doi: 10.1007/s00401-015-1403-6. Epub 2015 Feb 28.

18.

Large-scale conservation planning in a multinational marine environment: cost matters.

Mazor T, Giakoumi S, Kark S, Possingham HP.

Ecol Appl. 2014 Jul;24(5):1115-30.

PMID:
25154100
19.

The crowded sea: incorporating multiple marine activities in conservation plans can significantly alter spatial priorities.

Mazor T, Possingham HP, Edelist D, Brokovich E, Kark S.

PLoS One. 2014 Aug 7;9(8):e104489. doi: 10.1371/journal.pone.0104489. eCollection 2014.

20.

Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma.

Johnson BE, Mazor T, Hong C, Barnes M, Aihara K, McLean CY, Fouse SD, Yamamoto S, Ueda H, Tatsuno K, Asthana S, Jalbert LE, Nelson SJ, Bollen AW, Gustafson WC, Charron E, Weiss WA, Smirnov IV, Song JS, Olshen AB, Cha S, Zhao Y, Moore RA, Mungall AJ, Jones SJM, Hirst M, Marra MA, Saito N, Aburatani H, Mukasa A, Berger MS, Chang SM, Taylor BS, Costello JF.

Science. 2014 Jan 10;343(6167):189-193. doi: 10.1126/science.1239947. Epub 2013 Dec 12.

21.

Ecoregion-based conservation planning in the Mediterranean: dealing with large-scale heterogeneity.

Giakoumi S, Sini M, Gerovasileiou V, Mazor T, Beher J, Possingham HP, Abdulla A, Çinar ME, Dendrinos P, Gucu AC, Karamanlidis AA, Rodic P, Panayotidis P, Taskin E, Jaklin A, Voultsiadou E, Webster C, Zenetos A, Katsanevakis S.

PLoS One. 2013 Oct 14;8(10):e76449. doi: 10.1371/journal.pone.0076449. eCollection 2013.

22.

Poly-glutamine expanded huntingtin dramatically alters the genome wide binding of HSF1.

Riva L, Koeva M, Yildirim F, Pirhaji L, Dinesh D, Mazor T, Duennwald ML, Fraenkel E.

J Huntingtons Dis. 2012;1(1):33-45.

23.

Direct recruitment of polycomb repressive complex 1 to chromatin by core binding transcription factors.

Yu M, Mazor T, Huang H, Huang HT, Kathrein KL, Woo AJ, Chouinard CR, Labadorf A, Akie TE, Moran TB, Xie H, Zacharek S, Taniuchi I, Roeder RG, Kim CF, Zon LI, Fraenkel E, Cantor AB.

Mol Cell. 2012 Feb 10;45(3):330-43. doi: 10.1016/j.molcel.2011.11.032.

24.

Unbiased, genome-wide in vivo mapping of transcriptional regulatory elements reveals sex differences in chromatin structure associated with sex-specific liver gene expression.

Ling G, Sugathan A, Mazor T, Fraenkel E, Waxman DJ.

Mol Cell Biol. 2010 Dec;30(23):5531-44. doi: 10.1128/MCB.00601-10. Epub 2010 Sep 27. Erratum in: Mol Cell Biol. 2012 Feb;32(4):897.

25.

A quantitative model of transcriptional regulation reveals the influence of binding location on expression.

MacIsaac KD, Lo KA, Gordon W, Motola S, Mazor T, Fraenkel E.

PLoS Comput Biol. 2010 Apr 29;6(4):e1000773. doi: 10.1371/journal.pcbi.1000773.

26.

N-Benzyl-3-sulfonamidopyrrolidines as novel inhibitors of cell division in E. coli.

Mukherjee S, Robinson CA, Howe AG, Mazor T, Wood PA, Urgaonkar S, Hebert AM, Raychaudhuri D, Shaw JT.

Bioorg Med Chem Lett. 2007 Dec 1;17(23):6651-5. Epub 2007 Sep 7.

27.

Early pregnancy diagnosis in the ewe, based on milk progesterone levels.

Shemesh M, Ayalon N, Mazor T.

J Reprod Fertil. 1979 May;56(1):301-4.

Supplemental Content

Support Center